Tuesday, September 26, 2017 10:15 PM ET
Advaxis (ADXS) Insider Makes Significant Share Sale
There was a notable sale of shares of Advaxis by an insider today, as revealed in a form 4 document filed with the SEC. One insider — ADAGE CAPITAL PARTNERS GP, L.L.C., 10% Owner — sold 1,239,323 shares in the company having a market value of approximately $5,474,435. This is the first insider buy/sell trade in the past 90 days.
Advaxis level of buy-sell trading activity is close to the 182 member peer company average. The Biotechnology & Medical Research peer group saw 219 buy/sell trades during this period for an average of 1.2 transactions per company. However, the number of shares per buy/sell trade transacted by Advaxis insiders is higher. Within the peer group there were 8,567,507 shares purchased and 50,287,761 shares sold with company insiders having sold 190,503 shares on average.
Significant insider buying and selling activity has been determined by eliminating all trading activity reported to the SEC that involves awards, options, exercise of derivative securities, company buy-backs, taxes, gifts, shares acquired via inheritance and tenders or exchange offers in data used in creating and writing this story.
Using proprietary Natural Language Generation (NLG) technology, UpTick evaluates corporate insider filings reported to the SEC and creates real-time news and analysis to report the most significant insider transactions based on transaction type, size and historical trends.
For more information, contact UpTick at firstname.lastname@example.org. Copyright 2017 UpTick Data Technologies. All rights reserved.